1, VISABILITY™ MICRO INSERT SYSTEM FDA
网页The VisAbility Micro Insert System has been in development over the last 20 years as a treatment for presbyopia. The VisAbility Micro Insert ystem is unique among S ocular
Scleral Inserts | Ento Key
网页2019年9月1日 · These theories provide the basis for a scleral solution to restore dynamic accommodation. The VisAbility Micro-Insert System (Refocus Group) is a binocular presbyopia correction procedure performed outside the visual axis. Unlike static corrections such as corneal inlay technologies, monovision or multifocal laser vision correction, and
History of Changes for Study: NCT02374671
网页A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients Latest version (submitted December 17, 2019) on ClinicalTrials.gov A study version is represented by a row in the table.
Scleral Surgery for Presbyopia | Ento Key
网页2019年10月10日 · In a 24-month clinical trial with VisAbility Micro-Insert trials presented in 2013, 80 patients were asked to describe their unaided vision as “excellent,” “acceptable,” or “poor,” pre- and postoperatively. At 24 months, 73% patients
Clinical Trial on Presbyopia: VisAbility Micro Insert - Clinical
网页The purpose of this study is to evaluate the safety and effectiveness of the VisAbility Micro Insert System for the improvement of near visual acuity in .. Sponsors Lead Sponsor: Refocus Group, Inc. Source Refocus Group, Inc. Brief
Sclera Based Solutions to Presbyopia and the Aging Lens
网页Figure 1. Implantation of the VisAbility Micro Insert. Figure 2. The LSM procedure performed with the VisioLite device. Reprinted with permission from Hipsley et al.11 Figure 3. The LSM procedure performed with the VisioLite Gen I
VisAbility Micro Insert System
网页VisAbility Micro Insert System Instructions for Use Refocus Group, Inc. 92028 IFU v1 / ADYTPM Page 3 of 16 2. Peritomy Re-instill sterile 2% xylocaine drops without
Sclera-Based Solutions to Presbyopia and the Aging Lens
网页Implantation of the VisAbility Micro Insert. In January, results of a 360-patient FDA clinical trial with the device were posted on clinicaltrials.gov. 5 In this trial, patients at 14 sites received VisAbility Micro Inserts in their first eye, then
MillennialEYE | VisAbility Micro-Insert System for Presbyopia
June 9, 2020: Ophthalmic Devices Panel meeting
网页2020年4月28日 · The VisAbility Micro Insert is indicated for bilateral scleral implantation to improve unaided near vision in phakic, presbyopic patients between the ages of 45 and 60 years of age, who have a
History of Changes for Study: NCT03811249
网页Long Term Follow-up of the VisAbility Micro Insert System for Presbyopic Patients Latest version (submitted October 15, 2019) on ClinicalTrials.gov A study version is represented by a row in the table.
Capwell Communications | Public Relations
网页Strategic positioning, corporate and product PR for the VisAbility Micro insert for the treatment of presbyopia. Refractec Strategic positioning and award-winning publicity campaign for conductive keratoplasty (CK) turned this
Brief Summary Ophthalmic Devices Panel of the Medical
网页The VisAbility Micro Insert is indicated for bilateral scleral implantation to improve unaided near vision in phakic, presbyopic patients between the ages of 45 and 60 years of age, who have a
The future of refractive surgery: presbyopia treatment, can we
网页2020年9月7日 · Currently, the VisAbility Micro-Insert scleral implant (Refocus Group, Dallas, TX, USA) has a CE mark and is currently undergoing clinical trials []. However, there are risks from anterior segment
Going Small with Big Results: The VisAbility Micro-Insert System
网页2017年6月1日 · The VisAbility Micro-Insert from Refocus Group is the first and only presbyopic procedure performed outside the visual axis. by Michael Smolinsky, PhD, Chief Content Officer, Ethis In May of this year, Refocus Group (Dallas, TX) announced that it had completed enrollment of its Phase 3 clinical trial on the VisAbility™ Micro-Insert System